Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives
Author:
Publisher
Informa Healthcare
Subject
Pharmaceutical Science
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425247.2015.1078309
Reference95 articles.
1. Non–Cystic Fibrosis Bronchiectasis
2. Inhalation of Macrolides: A Novel Approach to Treatment of Pulmonary Infections
3. Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis
4. Prevalence and Economic Burden of Bronchiectasis
5. Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overcoming barriers in cystic fibrosis therapy through inhalational lipid nanoparticles: Challenges and advances;Journal of Drug Delivery Science and Technology;2023-11
2. Construction and performance evaluation of a sustained release implant material polyetheretherketone with antibacterial properties;Materials Science and Engineering: C;2021-07
3. Correlation and clinical relevance of animal models for inhaled pharmaceuticals and biopharmaceuticals;Advanced Drug Delivery Reviews;2020-12
4. Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections;European Journal of Clinical Microbiology & Infectious Diseases;2019-11-16
5. Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1);Pulmonary Pharmacology & Therapeutics;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3